Sarepta Therapeutics (SRPT) Granted FDA Accelerated Approval for Eteplirsen

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/18/2026

1. NVDA
2. DOO
3. ARGX
4. HD
5. SPY
6. KLAR
7. AMLX
8. METC
9. FN
10. TSLA

Go back to Sarepta Therapeutics (SRPT) Granted FDA Accelerated Approval for Eteplirsen
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 17.99 -0.19 (1.05%)
Previous Close $18.18    52 Week High $63.73 
Open $18.17    52 Week Low $8.00 
Day High $18.29    P/E N/A 
Day Low $17.88    EPS $-5.69 
Volume 648,698